Weight Loss Drug Developer Files For Liquidation
By Rick Archer · October 31, 2023, 5:47 PM EDT
Weight loss drug developer Gelesis Inc. has filed for Chapter 7 liquidation in a Delaware bankruptcy court with over $44 million in debt in the wake of a canceled merger with...
To view the full article, register now.